肠道菌群与非酒精性脂肪肝相关性的研究进展

被引:32
作者
陈默
孔银
王君
柳鹏程
王根年
魏丰贤
张岭漪
机构
[1] 兰州大学第二临床医学院
关键词
肠道菌群; 非酒精性脂肪肝; 研究进展;
D O I
暂无
中图分类号
R575.5 [肝代谢障碍];
学科分类号
100201 [内科学];
摘要
非酒精性脂肪肝(NAFLD)是我国最常见的慢性肝病之一,为非酒精性因素所致的肝细胞脂肪变为特征的综合征,包括单纯性脂肪肝(SFL)、非酒精性脂肪性肝炎(NASH)及其相关肝硬化和肝细胞癌(HCC)。人体肠道中的各种菌群发挥着不同的病理生理作用,与许多疾病密切相关,肠道菌群可以通过"肠-肝轴"影响NAFLD的发生发展,"二次打击"学说很好地解释了NAFLD的发病机制及其与肠道菌群的关系。益生元、益生菌可以很好地调节肠道菌群,与抗生素和手术相比更加廉价、无害、安全,有望成为预防和治疗NAFLD的新方法。本研究对肠道菌群与NAFLD相关性的研究进展加以综述。
引用
收藏
页码:989 / 993
页数:5
相关论文
共 21 条
[1]
Impact of the gut microbiota; prebiotics; and probiotics on human health and disease.[J].Chuan-Sheng Lin;Chih-Jung Chang;Chia-Chen Lu;Jan Martel;David Ojcius;Yun-Fei Ko;John Young;Hsin-Chih Lai.Biomedical Journal.2014, 5
[2]
Microbiota and nonalcoholic steatohepatitis [J].
Imajo, Kento ;
Yoneda, Masato ;
Ogawa, Yuji ;
Wada, Koichiro ;
Nakajima, Atsushi .
SEMINARS IN IMMUNOPATHOLOGY, 2014, 36 (01) :115-132
[3]
Intestinal Microbiota in Patients With Nonalcoholic Fatty Liver Disease [J].
Mouzaki, Marialena ;
Comelli, Elena M. ;
Arendt, Bianca M. ;
Bonengel, Julia ;
Fung, Scott K. ;
Fischer, Sandra E. ;
McGilvray, Ian D. ;
Allard, Johane P. .
HEPATOLOGY, 2013, 58 (01) :120-127
[4]
Role of the intestinal microbiome in liver disease.[J].Jorge Henao-Mejia;Eran Elinav;Christoph A. Thaiss;Paula Licona-Limon;Richard A. Flavell.Journal of Autoimmunity.2013,
[5]
Innate sensors of pathogen and stress: linking inflammation to obesity.[J].Chengcheng Jin;Richard A. Flavell.The Journal of Allergy and Clinical Immunology.2013,
[6]
Nonalcoholic Fatty Liver Disease.[J].Ding-You Li;Min Yang;Sarah Edwards;Shui-Qing Ye.Journal of Parenteral and Enteral Nutrition.2013, 6
[7]
Prebiotic approach alleviates hepatic steatosis: Implication of fatty acid oxidative and cholesterol synthesis pathways.[J].Barbara D. Pachikian;Ahmed Essaghir;Jean‐Baptiste Demoulin;Emilie Catry;Audrey M. Neyrinck;Evelyne M. Dewulf;Florence M. Sohet;Laurence Portois;Laure‐Alix Clerbaux;Yvon A. Carpentier;Sam Possemiers;Guido T. Bommer;Patrice D. Cani;Nathalie M. Delzenne.Mol. Nutr. Food Res..2012, 2
[8]
Role of gut microbiota in liver diseases.[J].Yasuhiro Miyake;Kazuhide Yamamoto.Hepatol Res.2012, 2
[9]
Features, Diagnosis, and Treatment of Nonalcoholic Fatty Liver Disease [J].
Torres, Dawn M. ;
Williams, Christopher D. ;
HarrisonO, Stephen A. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2012, 10 (08) :837-858
[10]
Gut–liver axis: The impact of gut microbiota on non alcoholic fatty liver disease.[J].D. Compare;P. Coccoli;A. Rocco;O.M. Nardone;S. De Maria;M. Cartenì;G. Nardone.Nutrition; Metabolism and Cardiovascular Diseases.2012, 6